Primary Cutaneous CD30-Positive Lymphoproliferative Disorders—Current Therapeutic Approaches with a Focus on Brentuximab Vedotin

Primary Cutaneous CD30-Positive Lymphoproliferative Disorders—Current Therapeutic Approaches with a Focus on Brentuximab Vedotin

One of the most common subgroups of cutaneous T-cell lymphomas is that of primary cutaneous CD30-positive lymphoproliferative disorders. The group includes lymphomatoid papulosis (LyP) and primary cutaneous anaplastic large cell lymphoma (pcALCL), as well as some borderline cases. Recently, signific...

Full description

Bibliographic Details
Main Authors: Tomasz Stein, Tadeusz Robak, Wojciech Biernat, Ewa Robak
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Journal of Clinical Medicine
Subjects:
anaplastic large cell lymphoma
brentuximab vedotin
CD30-positive lymphomas
diagnosis
lymphomatoid papulosis
primary cutaneous anaplastic large cell lymphoma
Online Access:https://www.mdpi.com/2077-0383/13/3/823

Similar Items

Similar Items